RxDoctor Payments Data

Julie Shaw, PA

Physician Assistant · Rome, GANPI 1982465720

Payments from drug & device makers

$897in general payments, 2019–2025

Across 53 payments — averaging $16.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$136
  • Novo Nordisk$130
  • Boehringer Ingelheim$94
  • Exact Sciences$92
  • Lilly USA, LLC$86
  • Tris Pharma Inc$82
  • plus $277 from 10 others

What the payments were for

  • Food & beverage$897100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$897 in reported general payments places this provider in the 65th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$2,177
Medicare patients
19
Services billed
36

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide34$41,290
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$13,140
Albuterol Sulfate HfaAlbuterol Sulfate41$1,037
Gabapentin25$360
Atorvastatin Calcium31$262
Quetiapine Fumarate12$211
Metoprolol Succinate13$210
Buspirone Hcl11$182
Fluticasone Propionate19$182
Hydrochlorothiazide21$166
Famotidine16$162
Escitalopram Oxalate17$158
Levothyroxine Sodium24$150
Omeprazole18$140
Hydroxyzine Hcl14$139

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$86$41,29034 claims
GSKTrelegy Ellipta$14$13,14012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Rome

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →